ArticlePDF AvailableLiterature Review

Restoration of Satisfying Sex for a Castrated Cancer Patient with Complete Impotence: A Case Study

Authors:

Abstract

We present a first-hand account of a fully impotent, testosterone-suppressed prostate cancer patient who has satisfying, multiorgasmic sex using a strap-on dildo. We use his narrative to examine dildos as an alternative to erectile dysfunction treatments for men, such as this patient, who find selective inhibitors of PDE-5 ineffective and surgical intervention unacceptable. We explore what conditions allowed this man to progress from suspicious distrust of the dildo to full acceptance. In terms of making a dildo acceptable to other patients, we contrast offering it to them as a penile prosthesis in a formal medical setting versus treating it as a toy in fantasy sex play. Last, we present a neurobiological hypothesis involving sensory integration to help explain why sex with the strap-on dildo can be satisfying to a male.
Journal of Sex & Marital Therapy, 32:389–399, 2006
Copyright © Taylor & Francis Group, LLC
ISSN: 0092-623X print
DOI: 10.1080/00926230600835346
Restoration of Satisfying Sex for a Castrated
Cancer Patient with Complete Impotence:
A Case Study
KAREN M. WARKENTIN
Department of Biology, Boston University, Boston, Massachusetts, USA
ROSS E. GRAY
Psychosocial & Behavioural Research Unit, Toronto Sunnybrook Regional Cancer Centre,
Toronto, Ontario, Canada
RICHARD J. WASSERSUG
Department of Anatomy & Neurobiology, Dalhousie University, Halifax, Nova Scotia, Canada
We present a first-hand account of a fully impotent, testosterone-
suppressed prostate cancer patient who has satisfying, multiorgas-
mic sex using a strap-on dildo. We use his narrative to examine
dildos as an alternative to erectile dysfunction treatments for men,
such as this patient, who find selective inhibitors of PDE-5 inef-
fective and surgical intervention unacceptable. We explore what
conditions allowed this man to progress from suspicious distrust of
the dildo to full acceptance. In terms of making a dildo acceptable
to other patients, we contrast offering it to them as a penile prosthe-
sis in a formal medical setting versus treating it as a toy in fantasy
sex play. Last, we present a neurobiological hypothesis involving
sensory integration to help explain why sex with the strap-on dildo
can be satisfying to a male.
We report a simple, noninvasive strategy for reestablishing orgasmic sex
without erections, based on the experiences of one prostate cancer patient,
and consider the implications of his experience for other patients and their
partners. The patient was diagnosed with prostate cancer 6 years earlier
We thank Deborah McLeod for helpful discussions. This study was supported by the Cana-
dian Institutes of Health Research through its Institute of Gender and Health.
Address correspondence to Richard J. Wassersug, Department of Anatomy & Neurobiology,
Sir Charles Tupper Medical Building 5850 College Street, Dalhousie University, Halifax, Nova
Scotia, B3H 1X5, Canada. E-mail: tadpole@dal.ca
389
390 K. M. Warkentin et al.
and had both a radical prostatectomy and salvage radiotherapy. He is now
in his late 50s, currently free of cancer symptoms but impotent from the
cancer treatments. He is on androgen deprivation therapy, via the LH-RH
agonist Lupron (leuprolide acetate), which suppresses the testosterone that
stimulates prostate cancer cell growth. This has reduced his testosterone
to castration levels, as confirmed by regular blood tests. He no longer has
erections and has a reduced libido, both typical effects of his treatment.
We have worked with the patient to construct the narrative and analysis
presented here and have his approval for the final version. However, he
wishes to remain anonymous.
Most treatments of erectile dysfunction (ED) focus narrowly on restor-
ing erectile function and coitus rather than on improving sexual satisfaction
within relationships. Here, we suggest the use of a strap-on dildo as a med-
ically noninvasive sexual alternative. Dildo sex allows full body contact and
natural, familiar movement patterns, combined with effective genital stim-
ulation. Moreover, it offers a security of sexual performance to the wearer
without the problematic intensification of the coital imperative implicit with
the use of pharmaceutical or surgical therapies for ED. We explore the idea
that dildo use can make sex a lower stress, more playful and collaborative
process.
Surveys and interviews with partially or fully impotent prostate cancer
patients repeatedly reveal great psychological distress associated with the loss
of sexual capability (Althof, 2002; Brucker & Cella, 2003; Clark et al., 2003;
Cooperberg et al., 2003; Dahn et al., 2004; Fergus, Grey, & Fitch, 2002; Gray
et al., 2002; Navon & Morag, 2004; Pirl, Siegel, Goode, & Smith, 2002; Schover
et al., 2004; plus older studies cited therein). Before cancer treatment, patients
are reassured by health professionals that there are interventions to help if
treatments cause impotence. But these interventions are only effective for a
fraction of patients (Schover et al., 2002). Patients on antiandrogen therapy
are particularly unlikely to find the common medical interventions helpful.
The patient discussed here has found a way to circumvent these problems.
HIS STORY
Neither Viagra nor a vacuum erection device worked for me. I am loath to
inject drugs into my penis or have a surgically implanted penile prosthe-
sis, the remaining medical options for treating ED. Not surprisingly, like so
many other cancer patients sexually incapacitated by modern medicine, I
was clinically depressed within a few months of starting hormonal therapy.
This situation began to change when a close lesbian friend, who was
aware of my cancer treatments and the sexual dysfunction they had caused,
refused to accept my giving up on life. She told me that she uses a strap-
on dildo. She claimed that she got genuine sexual satisfaction from this and
Satisfying Sex for a Castrated Cancer Patient 391
thought I could too. I was very skeptical. A dildo is not innervated, and
I imagined that sex performed with such an appliance would be wholly
contrived and not a sensual act at all. My friend persisted in encouraging me,
arguing that sexual satisfaction is as much in the brain as in the groin.
It took me more than a year to act on her suggestion. I was embarrassed
to go into a sex shop to buy a dildo. I had never used sex toys. I was
afraid that I would feel foolish and humiliated by using a strap-on penis.
To do so meant facing fully, frontally (so to speak), the functional failure
of my own flaccid phallus. Despite my reservations, I eventually agreed to
experiment with a strap-on dildo. My expectations, though, were muted. At
most, I thought I might be able to please my partner. But I honestly did not
envision recreating a fully satisfying sexual experience.
My lesbian friend took the initiative to get me going on this project. She
fabricated a harness that was customized to fit me and took me shopping for
a dildo, which she insisted I consider “a toy.” I don’t think I could have even
walked into the sex shop without her. I was worried that I might be identified
and mocked by someone who knew me. In the store I debated buying a
dildo that looked relatively natural or one that was beyond the realm of real
anatomy. I finally selected one that was similar in size, shape, and angle
to my erect penis before cancer treatments, to the best of my recollection.
It is made of silicone, which makes it durable, appropriately stiff, yet still
flexible, like a natural erect penis. Beyond that, the dildo that I bought bears
little resemblance to a human penis. Granted, it has an expanded “head,” like
the real glans penis but a uniformly smooth shaft, with none of the irregular
surface texture caused by real-life veins. And it is purple! Clearly, it does
not constitute a realistic bio-mimetic prosthesis. I knew then that I could not
seriously think of this piece of purple plastic as a medical appliance. This
was important in my reconceptualizing the situation. Whatever I was going
to do with the dildo was not in anyway a “cure” for ED nor was it meant
to restore my masculine sense of sexuality. If this was going to work, it was
because it was something completely different. I had to stop thinking about
this clinically and accept the idea that I was heading into the theater of the
absurd, and I was going to play the part of a lesbian!
Before this purchase, I discussed extensively with my partner whether
she was willing to have sex with me wearing a strap-on dildo. She was at
first hesitant but ultimately supportive of the exploration. We have now used
the dildo many times. It caught me by total surprise how natural intercourse
felt with this strap-on device. I discovered that my hip movements with the
dildo on were the same as during normal intercourse. Our body contact and
embrace was full and natural, as well. The first time that we used the dildo,
my partner reached down and held my penis in her hand. She had coated her
hand with the same lubricant used to coat the dildo and stimulated my penis
in synchrony with my pelvic movements. There was little sensory difference
between this act and intercourse—my penis was not in her vagina but it
392 K. M. Warkentin et al.
did not know that. It was in a wet, warm place being firmly mechanically
stimulated. My hindbrain took over, and I carried the act through to orgasm,
to the sexual satisfaction of both my partner and myself.
My partner had not discussed with me her plan to hold my glans penis, so
I was totally surprised by that action. I had not expected to achieve an orgasm
and was astonished that it happened. At first I, thought it was the novelty
of her holding my penis that brought me to climax. I thus feared that being
aware, and then self-conscious, of this activity would defeat its effectiveness.
This, however, has not been the case. If anything, sexual satisfaction has
become easier, because both of us have come to accept the dildo as part
of our sex play. Each time we use it, it becomes further imbued with the
knowledge of the previous sexual satisfaction it has provided. It is thus now
both a normal and at the same time erotic part of our lives.
We have both been able to have orgasms many times using the dildo.
The knowledge that it will never become flaccid means that my having an
orgasm need not prohibit further penetrative sex. The dildo gives me the
sexual capacity to serve my partner more reliably than I might have been
able to achieve as a potent male (with or without Viagra). Significantly, my
partner claims that she could not previously have an orgasm simply by penile
penetration. However, with the dildo, I am able to continue pelvic thrusts
long and hard enough that she now regularly achieves an orgasm in the
missionary position. We have also used the dildo with me lying on my back
and my partner sitting on it, so she has control of the movement. This was
sexually pleasurable for her, although I have not achieved an orgasm in this
position.
When I had a prostate gland, sexual arousal that did not lead to ejacula-
tion was frustrating, and I found it incomprehensible when a woman claimed
she had pleasure from sexual stimulation yet had not had an orgasm. After my
prostate was removed, I discovered that I too could have incremental plea-
sure from sexual stimulation and enjoy sex without orgasms. I can also have
multiple orgasms! Without a prostate gland, my orgasms are less anatomically
focused, radiating across my pelvis. They are of variable intensity but some-
times massively cathartic. When I have multiple orgasms, they are usually 2
or 3 within one minute or 2. I find it easiest to achieve orgasms when my
partner wants me to, especially in the context of mutually satisfying dildo
intercourse, but far more difficult on my own.
Iamfascinated by the eroticism that has developed between my partner,
myself, and our dildo. For example, one morning, after having sex the night
before, I went to the bathroom and found the dildo sitting upright on the
counter-top wearing one of my favorite neckties. My partner had decided to
personify and personalize it. I interpreted this as a signal to me that the dildo
pleased her and did so because of its association with me.
On another occasion, I was waiting for my partner’s arrival and decided
to put on the harness and dildo ahead of time. I covered myself and the
Satisfying Sex for a Castrated Cancer Patient 393
dildo with a bathrobe, but there was no mistaking the fact that when I looked
down there was sticking out what looked like a large firm erection. For a
brief instant, it brought back my fear that wearing a dildo would force me
to confront in a demoralizing fashion my own failed phallus, my mutilated
masculinity.
But that was not at all what I felt. Instead, I felt joyfully empowered.
My thoughts went to a glib one-liner from my lesbian friend: “A dyke with
a dildo can outlast a male anytime.” I realized that that was equally true
for a prostate cancer patient with a dildo, and I almost started laughing. I
was playing a role and doing it better than I ever could before I became
impotent. I had acquired a performance capability that surpassed “male” and
I was thoroughly enjoying the “play” part of sex.
When I reported this experience to my lesbian friend, she suggested that
my partner and I explore oral sex with the dildo. Once again, my first thought
was, “That’s absurd.” But since everything else she suggested had worked
better than I could have imagined, my partner and I took on the challenge.
Simply stated, there has now been enough acceptance of the dildo as a sexual
object—and transference from “object” to “organ”—that the visual image of
my partner mouthing the dildo was indeed highly erotic in the context of
our sex play. On another occasion, in order to tease me, my partner started
playing with the dildo in a flirtatious fashion outside of the bedroom. I found
the activity erotic and sufficiently distracting that I had to ask her to stop so
that I could concentrate on what I was doing.
DISCUSSION
On the Psychological Context of Dildo Refusal and Dildo Use:
Changes Over a 5-year Period
We believe several factors may have contributed to this man’s initial refusal
to try a strap-on dildo and his later acceptance and enthusiasm. First, his
relationship with the lesbian friend who suggested that he try the strap-on
is pivotal. He has been close to this woman for 16 years, and he considers
her a role model. Over the years, she has shared a great deal of personal
information with him about her nonerection–dependent sexual practices and
experiences.
Despite her recommendation and his high regard for her, he was un-
willing initially to try the dildo alternative. Key obstacles to him were the
unnatural appearance of the dildo and the fact that it was not innervated.
He felt that he would not be able to identify with this inanimate object; it
would not “be him.” At one point, he expressed mild interest in the possi-
bility of a personalized prothesis cast from a mold of his own erect penis.
But his impotence and aversion to injecting drugs into his penis to achieve
an erection precluded that possibility. At that time, he had a normal libido,
394 K. M. Warkentin et al.
despite his lack of erections. Hormonally, he was, and perceived himself to
be, fully male. He was frustrated with his sexual limitations but not depressed
or despairing. This is the period during which he tried Viagra and a vacuum
suction device.
When he began Lupron treatments, his attitude changed. He gave up
even the idea of sexuality and felt life was not worth living. After a few
months on Lupron, the turning point came when his lesbian friend finally
convinced him that his sexuality need not be testosterone dependent. He let
go of trying to regain what he had been before and embarked on a path
to create a new personal and sexual identity. The acceptance that he had
somehow fundamentally changed, on Lupron, allowed him to be more open
to a process of experimentation to find out who he could be, sexually, in
this new state.
As well as the continued support of his lesbian friend, a second pivotal
factor was a new sexual relationship. His partner is a woman with whom he
had been friends for many years. They had spoken at length about his cancer
treatments and their effects on him over the years, and she had been under-
standing and supportive. When she got involved with him, she knew his con-
dition and wanted to work with him to see what kind of sexuality they could
create together. Thus, although she was initially hesitant about the dildo,
she was fundamentally open to alternative sexual practices and to a process
of mutual discovery. Her support, openness, and active participation in the
process have been critical to the development of his new sexual practice.
Who Owns that Phallus?
A key component to the sexual satisfaction that this patient has achieved is
that he and his partner are working together. Her acceptance of the dildo
matches if not exceeds his, and his satisfaction is enhanced by the equality
that the partners achieve in their sex play. For dildo sex to be effective,
it likely requires, at least initially, a cooperative “suspension of disbelief”
and a willingness in both partners to play along with the game in order
to begin creating the positive experiences that will become self-reinforcing.
Such cooperation within a couple appears essential for a strap-on dildo to
work as well as it has for this man and his partner. Although this patient
acquired the dildo on his own, by the end of his narrative, he considers the
dildo to belong to both him and his partner. This joint ownership is quite
unlike a penis, which may act like it “has a mind of its own” (Friedman,
2001) but is clearly the sole property of the man of whose body it is a part. A
dildo is quite different. Since it is detachable, a woman can take possession
of it. She can share a sense of potency that was previously solely the man’s.
This seems to have happened in this case, where it works to the satisfaction
of both partners.
Satisfying Sex for a Castrated Cancer Patient 395
Is It a Medical Prosthesis or a Sex Toy?
A strap-on dildo is simple, inexpensive, and noninvasive. Yet this patient,
who was clearly quite distressed about his lost sexuality, was initially very
resistant to experimenting with such a device. This suggests that, although
some impotent men may be inspired to try dildo sex, others–probably many
others–may resist exploring this alternative.
The success in medical treatment of ED suggests that some patients may
be willing to consider dildo sex if it is prescribed by their physicians. Gray
and Klotz (2004) discuss this approach. For instance, a doctor could prescribe
a “belted prosthetic phallus” for his impotent patients and then refer them
to a sexuality clinic in a medical setting for instruction on how to use the
appliance. Although such medicalization of sexuality is problematic, it may
nevertheless be the most acceptable route for some couples.
For other patients, such as the man described here, a dildo may be more
effective if viewed not as a medical treatment for ED but as a sexual alterna-
tive or enhancement. For him, the dildo worked because “it was something
completely different,” a toy with which he and his partner played.Inorder
for him to achieve sexual satisfaction, he “had to stop thinking about this
clinically and accept the idea that [he] was heading into the theater of the
absurd.” It worked not because it was a medically prescribed treatment for
his disability but because it was a sex toy.
If other patients can profit from the experience of this man, careful con-
sideration must be given to the subtleties of how to introduce dildo sex to
patients. Some patients may find a “belted prosthetic phallus” acceptable
and a dildo not. For others, like this patient, it may be best to take sexual-
ity completely away from the medical arena of impotence, dysfunction, and
“treatment” for sexual failure and move it into the realm of play, communi-
cation, and a collaborative project with a partner. Toys have long been a part
of human play and human communication.
Is It an Acquired Fetish?
This patient rapidly shifted from his initial view of the dildo as a somewhat
ridiculous piece of purple plastic to finding it a highly erotic and personal ob-
ject in association with his partner. From one perspective, one may view this
as the development of a fetish. Effectively, the repeated positive experiences
that this man and his partner have had with the dildo transformed it in both
of their minds into a sexually charged object and created a mutual sense of
ownership. This suggests that couples need not approach dildo sex with the
idea that it will work for them or any prior sense of eroticism associated with
the object. They need only the willingness to try it, to experiment. Any posi-
tive reinforcement through sexual satisfaction will increase the effectiveness
of the dildo as a sex toy or tool for them in the future.
396 K. M. Warkentin et al.
On the Biomechanics of Copulation and the Dildo Advantage
Although using a strap-on dildo may initially seem a poor match to natural
penile copulation, it has several mechanical advantages over treatments that
focus on achieving an erection for vaginal penetration. Vacuum devices and
many penile implants distend the shaft of the penis but do nothing to stiffen
the root of the penis within the body. This leads to a “hinge” effect, where
the shaft is stiff, but freely bends at its base. Similarly, drug treatments such
as Viagra, unless they are 100% effective, leave the penis only semifirm.
These conventional interventions may produce a “stuffable” penis but make
it difficult to maintain normal copulatory movements. Coitus is then easily
interrupted. This is a common problem with these treatments, which can be
extremely frustrating for both the man and his partner (Tomlinson & Wright,
2004).
A dildo completely circumvents this problem. A strap-on dildo can
closely match the natural size, shape, stiffness, and angle of a man’s erect
penis, allowing him to make completely natural hip thrusts. Even though
he cannot feel the dildo within his partner, he can move naturally without
fear of coming out of the vagina. Our patient credits these movements and
associated full body sensations with a critical role in his reestablishment of
orgasmic sexuality.
Also, when traditional ED treatments are not completely effective, they
fail to provide adequate stimulation to the glans penis during intercourse.
Without the penis being fully erect and at the proper angle, pressure on
the penis and stimulation to the glans is reduced. Many men after surgery,
radiation, and hormonal therapy report that they need extra penile stimu-
lation to achieve an orgasm. All current treatments for ED, however, focus
on vaginal penetration rather than glans stimulation.Infairness, these treat-
ments are designed to help the male recover coital capability. However, if
they are not fully effective, they cause less rather than greater stimulation to
the glans. In using a strap-on dildo, the penis is external so it can be stim-
ulated manually, providing more pressure to the glans. It is not obvious to
the penis itself where it is (Friedman, 2001). Provided it is in a moist envi-
ronment and stimulated firmly and rhythmically, the sensation can induce a
climax.
Finally, when traditional ED treatments are not perfect, they can under-
mine a man’s confidence in his ability to provide sexual satisfaction to his
partner. The acceptance of a dildo circumvents this psychological problem,
because both the man and partner can be fully confident that the dildo will
remain erect.
Although the sex described here is farther from natural intercourse than
that provided by other ED therapies, it offers enhanced penile and vaginal
stimulation. Consequently, it may be more sexually satisfying for both part-
ners than what can be achieved with other ED treatments that focus only on
penile penetration.
Satisfying Sex for a Castrated Cancer Patient 397
A Neurobiological Hypothesis on Dildo Eroticism
Recently, Ehrsson, Spince, and Passinghan (2004) used functional magnetic
resonance imaging (fMRI) to explain the strange “rubber-hand illusion.” In
this illusion, a person watching a brush stroking an artificial hand, while his
or her own hand is out of sight but simultaneously being stroked, develops
a sense that the rubber hand is their own. The fMRI established that the
illusion happens because of “multisensory integration in the premotor cortex”
(Ehrsson et al., 2004, p. 876).
Could a similar illusion apply to the strap-on dildo? Part of the psycho-
logical success of the dildo for our patient was how “real” it both felt and
looked to him. When it was strapped to his hips by the harness, it rested on
his pelvis in the natural position and angle of his own erect penis, before he
was impotent. This allowed for full body contact between him and his part-
ner in a completely natural, copulatory posture. Thus this may have provided
enough proprioceptive and tactile stimuli to produce sufficient “self-specific
intersensory correlations” (Botvinick, 2004) for a sensory illusion, like the
rubber-hand illusion, to occur.
During coitus in the missionary position, this man could not see the
dildo. Hence, this is not completely analogous to the rubber-hand illusion,
which involves integration of visual and tactile stimulation. However, Ehrsson
et al. have extended their earlier work on multisensory integration to show
that visual input is not essential and that multiple sensory information of
a purely tactile nature can induce the same illusion of ownership (Ehrsson
et al. 2005). Our patient describes intense erotic sensation from both sexual
intercourse in the missionary position with the strap-on dildo and watching
his partner performing fellatio on the dildo. Given concurrent manual stim-
ulation to the man’s flaccid but out of sight penis, these situations would
closely mimic the simultaneous tactile-tacile and visual-tacile input in the
rubber-hand illusion.
Of course, it remains to be seen if multisensory integration takes place in
the brain to provoke a genuine genital illusion equivalent to the rubber-hand
illusion as described by Ehrsson et al. (2004, 2005). Having a man in an fMRI
machine wearing a dildo while his partner has the dildo in either her vagina
or her mouth and simultaneously strokes his penis, sounds like the ultimate
kinky science experiment. Yet there is a serious context for doing such a
study. Establishing a solid neuroanatomical basis for a “rubber-penis illusion”
may help make a strap-on dildo an acceptable, noninvasive, cost-effective
treatment for ED for the 85% of men treated each year for prostate cancer
who experience some ED as a result of their treatment (Schover et al., 2002).
CONCLUSION
A strap-on dildo, in conjunction with manual penile stimulation, allowed our
fully impotent patient to achieve sexual satisfaction and concurrently satisfy
398 K. M. Warkentin et al.
his partner (Gray & Klotz, 2004). For some impotent patients, this simple
noninvasive approach may work better than more established ED treatments.
More research is needed to see how effective a dildo is for other patients
and, if it is effective, to identify the best way of presenting this option to
patients and their partners.
It should be noted that the current cost of one dose of Viagra or similar
drugs (e.g, vardenafil, adalafil) is $8–10 US. The cost of a penile implant
generally ranges from $12,000 to 25,000 US. The total cost of a good quality,
off-the-shelf dildo and harness is less than $200 US.
REFERENCES
Althof, S. E. (2002). Quality of life and erectile dysfunction. Urology, 59, 803–810.
Botvinick, M. (2004). Probing the neural basis of body ownership. Science, 305,
782–783.
Brucker, P., & Cella, D. (2003). Measuring self-reported sexual function in men with
prostate cancer. Urology, 62, 596–606.
Cooperberg, M. R., Koppie, T. M., Lubeck, D. P., Ye, J., Grossfeld, G. D., Mehta,
S. S., & Carroll, P. R. (2003). How potent is potent? Evaluation of sexual function
and bother in men who report potency after treatment for prostate cancer: Data
from CaPSURE. Urology, 61, 190–196.
Clark, J. A., Inui, T. S., Silliman, R. A., Bokhour, B. G., Krasnow, S. H., Robinson,
R. A., Spaulding, M., & Talcott, J. A. (2003). Patients’ perceptions of quality of
life after treatment for early prostate cancer. Journal of Clinical Oncology, 21,
3777–3784.
Dahn, J. R., Penedo, F. J., Gonzalez, J. S., Esquiabro, M., Antoni, M. H., Roos, B. A.,
& Schneiderman, N. (2004). Sexual functioning and quality of life after prostate
cancer treatment: Considering sexual desire. Urology, 63, 273–277.
Ehrsson, H. H., Spence, C., & Passingham, R. E. (2004). That’s my hand! Activity
on the premotor cortex reflects feeling of ownership of a limb. Science, 305,
875–877.
Ehrsson, H. H., Holmes, N. P., & Passingham, R. E. (2005). Touching a rubber hand:
Feeling of body ownership is associated with activity in multisensory brain areas.
Journal of Neuroscience, 25, 10564–10573.
Fergus, K. D., Gray, R. E., & Fitch, M. I. (2002). Sexual dysfunction and the preser-
vation of manhood: Experiences of men with prostate cancer. Journal of Health
Psychology, 7, 303–316.
Friedman, D. M. (2001). A mind of its own: A cultural history of the penis. London:
Penguin.
Gray, R. E., Fitch, M., Phillips, C., Labrecque, M., Fergus, K., & Klotz, L. (2002).
Prostate cancer and erectile dysfunction: Men’s experiences. International
Journal of Men’s Health, 1, 5–20.
Gray, R. E., & Klotz, L. (2004). Restoring sexual function in prostate cancer
patients: An innovative approach. Canadian Journal of Urology, 11, 2285–
2289.
Satisfying Sex for a Castrated Cancer Patient 399
Navon, L. L., & Morag, A. (2004). Liminality as biographical disruption: Unclassifia-
bility following hormonal therapy for advance prostate cancer. Social Science &
Medicine, 58, 2337–2347.
Pirl, W. F., Siegel, G., Goode, M. F., & Smith, M. R. (2002). Depression in men
receiving androgen deprivation therapy for prostate cancer: a pilot study. Psy-
chooncology, 11, 518–523.
Schover, L. R., Fouladi, R. T., Warneke, C. L., Neese, L., Klein, E. A., Zippe, C., &
Kupelian, P. A. (2004). Seeking help for erectile dysfunction after treatment for
prostate cancer. Archives of Sexual Behavior, 33, 443–454.
Schover, L. R., Fouladi, R. T., Warneke, C. L., Neese, L., Klein, E. A., Zippe, C., &
Kupelian, P. A. (2002). The use of treatments for erectile dysfunction among
survivors of prostate carcinoma. Cancer, 95, 2397–2407.
Tomlinson, J., & Wright, D. (2004). Impact of erectile dysfunction and its subsequent
treatment with sildenafil: Qualitative study. British Medical Journal, 328, 1037–
1040.
... 13 This was further discussed in a case study presented by Warkentin et al 14 of a man, who had severe ED due to prostate cancer treatments include androgen deprivation therapy, but was able to achieve satisfactory orgasmic sex with his female partner while using an EPP. 13,14 Using an EPP for penetrative sex may have several advantages over standard ED treatments. For example, an EPP is relatively simple to use, inexpensive, non-invasive, with no pharmacological side effects. ...
... By holding the penis with lubricant in their hand, the partner can stimulate the penis in rhythm with the patient's normal hip movements, duplicating the stimulus he would receive during normal penetrative sex. Warkentin et al 14 suggests that the combined penile stimulation and normalcy of the full body posture and movements contributes to multi-sensory integration which culminated in orgasm for both the man using the EPP and for his partner. ...
... Having an EPP like the man's previous natural erect penis may allow the patients and their partners to psychologically accept the EPP more easily, as an 'extension' of themselves, rather than a foreign object. This mental transference was observed in Warkentin et al 14 where the patient, through significant acceptance of the dildo as an "organ" rather as an "object," was able to derive sexual pleasure from oral stimulation provided by his partner to his EPP, despite it not being his own penis. 14 Furthermore, partners may also be more comfortable with an EPP of a size they are familiar with and may be apprehensive if the EPP is unlike their partner's normal erect penis in size, shape and color. ...
Article
Full-text available
Introduction Erectile dysfunction (ED) can lead to reduced sexual intimacy in men. The external penile prosthesis (EPP) is a device to help them participate in penetrative sex. Aim We investigate factors that may affect the willingness of individuals with ED to try an EPP and explore how the EPP could be presented most effectively to such patients to enhance their willingness to try an EPP. Methods Recruitment for this cross-sectional study occurred in-person and online. 147 participants (60.0 ± 14.3 years old; all experiencing self-reported ED) completed a survey containing both validated measures and questions specific to this study. The survey was open to English-speakers over the age of 18 who self-reported experiencing ED. Main Outcome Measure The primary outcome was participants’ willingness to try an EPP based on their level of knowledge about using the EPP. Secondary outcomes included the influence of the sexual function, sexual distress, ED history, age, relationship duration, sexual flexibility on willingness to try an EPP. We also collected feedback from participants’ on how and where they would like to be introduced to the EPP option. Results Most participants indicated a preference for being introduced to the EPP after trying some ED treatments (51.0%). Participants did not have strong preference regarding the setting where they were informed about the EPP. The majority however preferred having a sexual health therapist/counsellor (28.6%) or physician (25.9%) as the person introducing the EPP to them. Participants’ willingness to try the EPP increased with more information about the EPP presented to them (P < .001). Personalization of the EPP to match one's own penis was preferred by 38.7% of participants. Referring to this aid as an ‘external penile prosthesis’ was significantly more preferred over alternative labels, such as a “belted prosthetic phallus” or “strap-on dildo” (Ps < .001 for both). Multiple regression analyses showed that only sexual script flexibility was associated with the initial willingness to try an EPP (P < .01). Clinical Implications Clinicians should consider presenting the EPP to men with ED, who desire maintaining penetrative sexual intercourse with their partners. Strength and Limitations This is the first study to explore factors influencing the willingness to try an EPP. Further research is needed to establish the efficacy of EPPs for maintaining sexual activity and satisfaction in the real-life setting. Conclusion This study informs clinicians about effective ways to introduce the EPP to patients with ED who wish to maintain insertive/receptive sex. Fu F, Duthie CJ, Wibowo E, et al. Openness to Using an External Penile Prosthesis for Maintaining Sexual Intimacy by Individuals with Erectile Dysfunction: A Cross-Sectional Study. Sex Med 2022;XX:XXXXXX.
... In one, penile tumescence is maintained approximately 50% of the time following orgasm; 10 in the other, a man in his late 50s gradually developed the ability to have multiple intense, nonejaculatory orgasms despite a complete inability to have an erection resulting from radical prostatectomy. 16 Hite suggests that if stimulation is necessary to regain erection for orgasms after the first, the term "sequential" rather than "multiple" orgasm is more appropriate. 17 While little is known about the variation in the experience of multiple orgasm in men, there is even less information about associated sexual histories and developmental patterns. ...
... Some authors have suggested that the presence of a familiar and empathic partner would facilitate the experience 19 while others have suggested the importance of a flexible attitude to non-traditional sexual scripts. 16 The small literature on male multiple orgasm is composed, in large part, of case studies; the existing group studies often have small Ns and use varying methodologies with different or vague definitions of multiple orgasm making them difficult to compare. The following study attempts to remedy this situation by using a systematic data collection method in a relatively large sample. ...
Article
Background The scientific literature on multiple orgasm in males is small. There is little consensus on a definition, and significant controversy about whether multiple orgasm is a unitary experience. Aims This study has 2 goals: (i) describing the experience of male multiple orgasm; (ii) investigating whether there are different profiles of multiple orgasm in men. Methods Data from a culturally diverse online convenience sample of 122 men reporting multiple orgasm were collected. Data reduction analyses were conducted using principal components analysis (PCA) on 13 variables of interest derived from theory and the existing literature. A K-means cluster analysis followed, from which a 4-cluster solution was retained. Results While the range of reported orgasms varied from 2 to 30, the majority (79.5%, N = 97) of participants experienced between 2 and 4 orgasms separated by a specific time interval during which further stimulation was required to achieve another orgasm. Most participants reported maintaining their erections throughout and ejaculating with every orgasm. Age was not a significant correlate of the multiple orgasm experience which occurred more frequently in a dyadic context. Four different profiles of multiorgasmic men were described. Strengths & Limitations This study constitutes a rare attempt to collect systematic self-report data concerning the experience of multiple orgasm in a relatively large sample. Limitations include the lack of validated measures, memory bias associated with self-reported data and retrospective designs, the lack of a control group and of physiological measurement. Conclusion Our study suggests that multiple orgasm in men is not a unitary phenomenon and sets the stage for future self-report and laboratory study. Griffin-Mathieu G, Berry M, Shtarkshall RA, Amsel R, Binik YM, Gérard M. Exploring Male Multiple Orgasm in a Large Online Sample: Refining Our Understanding. J Sex Med 2021;XX:XXX–XXX.
... The use of dildos has also been recommended in patients with ED after prostate cancer treatment because use of this device can help overcome fear of erectile failure, offering improved satisfaction for patients and their partners (TAble 1). Gray and Klotz 83 and Warkentin et al. 84 have described cases in which neurobiological integration, for example by using a sexual device, has helped a man progress from distrust to acceptance and satisfaction 42 . ...
... Penile rings and penile sleeves (for example, Fleshlight), which can be designed with or without vibration, are designed to fit the outer surface of the penile shaft and are made from flexible materials such as silicone or SuperSkin microfibre. No independent trials have validated their use; however, case reports describe how these devices can be used for partnered sexual stimulation and for self or mutual masturbation and might increase the sexual sensory experience in both abled and disabled persons 83,84,107 (TAble 1). ...
Article
Given that sexual pleasure is a core component of sexual health, devices that are designed to enhance and diversify sexual pleasure are particularly useful in clinical practice. Despite their growing popularity and widespread use in various biopsychosocial circumstances, many taboos still seem to exist, as indicated by the paucity of scientific literature on the prevalence, application and effectiveness of sexual devices for therapeutic use. However, sex toys and sexual devices are commonly used and have a variety of indications to expand individual and partnered sexuality and to treat sexual difficulties. Different devices are associated with specific advantages and potential risks, opportunities, barriers and ethical challenges when used in a clinical context. Increased knowledge about the aim and functional possibilities of sexual devices might help health-care professionals overcome potential embarrassment, preconceptions and other barriers, learn which patients might benefit from which products, consider their use in treatment programmes, educate about correct use and safety issues, and facilitate open communication about sexual pleasure with their patients.
... Wat te doen als uit de anamnese blijkt dat penetratie voor de vrouw wel degelijk belangrijk is? Warkentin schreef in 2006 een uiterst leerzame casus over een heteroseksuele man met PCa [42]. Zes jaar na radicale chirurgie, radiotherapie en ADT had hij nauwelijks zin in seks en helemaal geen erectie meer. ...
Article
Full-text available
Samenvatting Urologie en seksuologie hebben verschillende rollen bij de aanpak van prostaatkanker. De uroloog probeert het kankerproces te stoppen of traineren, terwijl de seksuoloog intussen focust op wat gebeurt met seksualiteit en intimiteit. Dit artikel kijkt naar de opeenvolgende stappen in het kankerproces met als belangrijke boodschappen: ‘Hou aandacht voor seksualiteit!’ en ‘Hou rekening met de grote diversiteit!’. Omdat seks voor sommige mannen en relaties heel belangrijk is en voor andere helemaal niet, is een goede, uitgebreide seksuele anamnese noodzakelijk. Hoe zien hun seksuele gedrag, relatie en verwachtingen er uit? Die informatie vormt hun ‘lovemap’, belangrijke elementen bij de keuze voor een bepaalde behandelstrategie. Vooral bij MSM lijkt koppeling van lovemap aan shared decision making een waardevolle aanvulling. Daarnaast krijgen ook seksuele prevalidatie ( Better in, better out! ), seksuele revalidatie en seksuele relatie aandacht. Waar de uro-oncologie focust op ‘ adding years to life ’, focust de seksuologie op ‘adding sexual life to years’ .
... Such resources may be similarly valued by cisgender men receiving ADT or by patients managing penectomy following penile cancer. 6 My cancer and gender-affirming transition journeys have led me to reconsider the platitude offered to patients undergoing treatment or excision: "The parts do not make the woman or man, do they?" We as providers should not assume what body parts mean to transgender patients with cancer-as there is just as much diversity within the transgender community as there is in any other community of patients. ...
... Specifically, 26% of penile sleeve buyers and 65% of penile support device buyers have PCa [11] and Wibowo et al. found 9% of men with PCa on androgen deprivation therapy (ADT) with erectile dysfunction had used sex toys for sexual activity [12]. In one case report, a man with PCa used a strap-on dildo for sexual activity after he had sexual problems following PCa treatment [13]. Beyond this research, however, little research examines factors associated with sexual management strategies use. ...
Article
Full-text available
Many men experience sexual difficulties after receiving prostate cancer treatment. We investigated sexual and relationship factors associated with management strategies to maintain sexual activity in prostate cancer patients. 210 prostate cancer patients (66.7 ± 7.4 years old) completed our survey online. Higher sexual function distress (Incidence rate ratio, IRR = 0.99, p = 0.005) and less frequent relationship strain (IRR = 1.01, p = 0.002) were associated with trying a higher number of sexual management strategies. Higher sexual function distress was associated with the use of oral medication (Odds Ratio, OR = 0.98, p = 0.026), vacuum erection device (OR = 0.98, p = 0.005), and vibrators (OR = 0.97, p = 0.005). Perceived importance of sexual interaction with a partner was associated with using oral medication (OR = 1.95, p = 0.027). Participant’s higher ideal frequency of sexual interaction with a partner was a predictor for the use of vibrators (OR = 1.03, p = 0.024). Less frequent relationship strain was associated with the use of vacuum erection device (OR = 1.03, p = 0.002), and vibrators (OR = 1.02, p = 0.012). Lastly, patients’ communication with their partner about sexual intimacy was also associated with use of vacuum erection device (OR = 3.24, p = 0.050, CI 1.0–10.5). Few participants (13–27%) were interested in trying penile implant, penile support device, external penile prosthesis, penile sleeve and anal devices. From our qualitative analyses, the main barriers to retaining sexual activity were erectile dysfunction and psychological issues. Three themes participants found useful to maintain sexual activity: preparatory behaviours for initiating or maintaining erections, adapting their sexual activity to fit with what was now possible, and the importance of the relationship or intimacy with their sexual partner. Psychological and relationship factors contribute to patients’ motivation to remain sexually active after treatment.
... In humans, ejaculation and orgasm may be perceived as a single event, even though they are not the same biological process [9]. Furthermore, there is evidence that some men can have an ejaculation without having an orgasm [10,11], and some men can have an orgasm without an ejaculation [12][13][14][15]. There are also case reports on men who can have multiple ejaculations within a short period, but they required at least a few minutes of sexual stimulation between ejaculations [16,17]. ...
Article
Full-text available
Mounting, intromission and ejaculation are commonly reported sexual behaviours in male rats. In a mating session, they can have several copulatory series with post-ejaculatory intervals in between ejaculations before they reach sexual satiety. Here, we describe a phenomenon where male rats displayed consecutive ejaculations (CE) with a short inter-ejaculatory interval (IEI). Male rats were daily mated with a sexually receptive female rat. Two out of 15 rats displayed CE in one of their mating tests. The first rat had CE at 9.9 and 10.1 min (IEI = 16.3 s) after the start of the test. The second rat showed CE at 28.1 and 28.5 min (IEI = 18.7 s) after the test onset. During the IEI, the rats did not show any mounting or intromission.
... A few heterosexual patients in that study reported exploring the use of anal stimulation via sex toys, including a case report of a heterosexual man who became interested in being anally penetrated subsequent to the loss of his own erections. In another case (Warkentin et al., 2006), a PCa patient on ADT, who had ED and reduced libido, experimented with vaginal intercourse using a strap-on dildo, recommended to him by a lesbian friend. To his surprise, he managed to achieve multiple orgasms during the intercourse; something he had not experienced prior to being on ADT. ...
Article
Androgen deprivation therapy (ADT) is a common treatment for men with systemic prostate cancer. However, ADT leads to sexual dysfunction, causing >80% of couples to cease sexual activity completely. Here, we use a biopsychosocial framework to review factors that may influence the ability of patients on ADT to remain sexually active. We address sexual factors prior to ADT, neurobiological factors, intermittent ADT, sex aids, exercise, sleep, partner factors, masculinity, non-penetrative intimacy, depressive symptoms, and access to counselling or patient education programs. We make suggestions for future research in order to extend our understanding in this field with the goal of improving evidence-based treatment protocols and practice. Importantly, we suggest that clinicians should discuss options for sexual intimacy after ADT with both patients and their partners, as sexual inactivity is not inevitable for most, and strategies are available for helping maintain sexual intimacy.
Article
Full-text available
Background Preservation of erectile function is an important postoperative quality of life concern for patients after robot-assisted radical prostatectomy (RARP) for prostate cancer. Although erectile function may recover, many men continue to suffer from erectile dysfunction (ED). Aim This study aims to determine whether satisfaction with sexual life improves in patients with ED after RARP and which factors are associated with satisfaction during follow-up. Methods A review was carried out of a prospectively maintained database of patients with prostate cancer who underwent a RARP between 2006 and 2019. The “International Index of Erectile Function” questionnaire was used to describe ED (range 5-25), overall satisfaction with sexual life and sexual desire (range for both: 2-10). Patients with ED due to RARP were compared with those without ED after RARP. Mixed effect model was used to test differences in satisfaction over time. Mann-Whitney U tests and multiple logistic regression were used to assess factors associated with being satisfied at 24 and 36 months. Outcomes The main outcomes of this study are the overall satisfaction with sexual life score over time and factors which influence sexual satisfaction. Results Data of 2808 patients were reviewed. Patients whose erectile function was not known (n = 643) or who had ED at the baseline (n = 1281) were excluded. About 884 patients were included for analysis. They had an overall satisfaction score of 8.4. Patients with ED due to RARP had mean overall satisfaction scores of 4.8, 4.8, 4.9, and 4.6 at 6 mo, 12 mo, 24 mo, and 36 mo. These scores were significantly lower than those of patients without ED at every time point. In multiple regression analysis, higher overall satisfaction score at the baseline and higher sexual desire at 24 and 36 months' follow-up were associated with satisfaction with sexual life at 24 and 36 months’ follow-up. No association was found for erectile function. Clinical implications Interventions focusing on adjustment to the changes in sexual functioning might improve sexual satisfaction; especially for those men who continue to suffer from ED. Strengths & Limitations Strengths of this study are the large number of patients, time of follow-up, and use of multiple validated questionnaires. Our results must be interpreted within the limits of retrospectively collected, observational data. Conclusion Satisfaction with sexual life in men with ED due to RARP may take a long time to improve. One could counsel patients that sexual satisfaction is based on individual baseline sexual satisfaction and the return of sexual desire after RARP. Albers LF, Tillier CN, van Muilekom HAM, et al. Sexual Satisfaction in Men Suffering From Erectile Dysfunction After Robot-Assisted Radical Prostatectomy for Prostate Cancer: An Observational Study. J Sex Med 2020;XX:XXX–XXX.
Article
Sexual dysfunction and insomnia are common side effects of prostate cancer (PCa) treatment, but the link between these symptoms has not been explored. We explore here the association between various sexual parameters and insomnia symptoms in PCa patients. Data were collected via an online survey with recruitment through various PCa organizations. One hundred and forty two patients (age = 67.3 ± 8.9 years) completed the survey. The majority were in a relationship (84.6%), of Caucasian ethnicity (83.1%), and 33% had previously received androgen deprivation therapy (ADT). Control variables—age, number of comorbidities, past ADT use, body mass index, depression, anxiety, fatigue and daytime sleepiness—explained 58.2% of the variance for insomnia symptoms. Including orgasm difficulty in the models accounted for an additional 2.1% in the variance in insomnia symptoms. Conversely, the control variables listed above together with insomnia symptoms predicted 37.7% of the overall variance in orgasm difficulty in PCa patients. These data suggest that sexual rehabilitation programs for PCa patients should assess insomnia symptoms, and therapies to improve sexual function or sleep quality may be beneficial in both functions given the relationship between sleep and orgasm functions in this population.
Article
Full-text available
Treatment for early prostate cancer produces problematic physical side effects, but prior studies have found little influence on patients' perceived health status. We examined psychosocial outcomes of treatment for early prostate cancer. Patients with previously treated prostate cancer and a reference group of men with a normal prostate-specific antigen (PSA) level and no history of prostate cancer completed questionnaires. Innovative scales assessed behavioral consequences of urinary dysfunction, sexuality, health worry, PSA concern, perceived cancer control, treatment decision making, decision regret, and cancer-related outlook. Urinary, bowel, and sexual dysfunction were assessed with symptom indexes; health status was assessed by the Physical and Mental Summaries of the Short Form (SF-12) Health Survey. Compared with men without prostate cancer, prostate cancer patients reported greater urinary, bowel, and sexual dysfunction, but similar health status. They reported worse problems of urinary control, sexual intimacy and confidence, and masculinity, and greater PSA concern. Perceptions of cancer control and treatment decisions were positive, but varied by treatment: prostatectomy patients indicated the highest and observation patients indicated the lowest cancer control. Bowel and sexual dysfunction were associated with poorer sexual intimacy, masculinity, and perceived cancer control; masculinity and PSA concern were associated with greater confidence in treatment choice; and diminished sexual intimacy and less interest in PSA were associated with greater regret. The lack of change in global measures of health status after treatment for early prostate cancer obscures important influences in men's lives; cancer diagnosis and treatment complications may result in complex outcomes. Aggressive treatment may confer confidence in cancer control, yet be countered by diminished intimate relationships and masculinity, which accompany sexual dysfunction.
Article
This paper draws on the results of a longitudinal, qualitative study of men with prostate cancer and their spouses. Thirtyfour men with prostate cancer and their spouses were interviewed (simultaneously and separately) at three points in time: prior to surgery; eight to 10 weeks post-surgery; and 11 to 13 months post-surgery. The primary focus for this paper is on the final set of interviews with the men, (although women’s responses are also reported upon). Whereas sexuality had not been a primary concern for men in earlier interviews, it surfaced in a major way in the interviews conducted a year after their treatment. Most of the men (71%) were totally impotent, and all of the rest were dealing with some loss of capacity. Six components of sexuality-related experience emerged from interviews, including 1) moving sex to the foreground; 2) navigating biotechnology (or not); 3) working things out as a couple; 4) coming to terms with the new me; 5) keeping things private; and 6) revisiting the treatment decision. While men tend to publicly downplay the impact of their illness experience, including erectile dysfunction, in reality they face major challenges in sorting through biotechnological remedies to impotence and in negotiating new sexual terrain with their partners.
Article
Journal of the History of Sexuality 12.2 (2003) 323-326 At least in print, the essential male organ seems finally to have achieved visibility in the United States, although mainstream Hollywood still resists true visual representation, in spite of the examples of Europe, Latin America, and its own neighboring porn film industry. David Friedman's new book makes a large claim as a cultural history but in fact represents what might be called high journalism, neither acceptably historical nor cultural. The author, an urbane New York journalist (for Esquire, GQ, etc.) who writes with wit and bons mots, organizes his essay in terms of the old schoolroom chronology: from Mesopotamia to Greece, Rome, and the Renaissance; then to modern Western medical research, including nineteenth-century obsessions with masturbation and circumcision, especially in the United States; and finally to Freud, feminism, and Viagra. This "history" contains all the usual suspects—Plato, Origen, Augustine, Leonardo, Vesalius, Leeuwenhoek, Krafft-Ebing, Freud and Jeffrey Masson, Whitman, Faulkner—and many others this reader had never heard of. It purports to identify major "paradigm shifts" in attitude toward the organ, from a positive, fertile "sacred staff" to a corrupt and corrupting "demon rod," with Augustine as the primary culprit. Then Leonardo plays a pivotal role in a new shift to secular appreciation and investigation, resulting first in the social-psychological perspectives of Freud and modern feminism and culminating in the technological triumph of anti-impotence pharmaceuticals. These overly simple ideological transformations are contradicted by material within the text itself, and, in any case, no explanation for these shifts, other than great men's ideas, is given. The authorities cited will be familiar to readers of this journal: for the classical world, Dover, Halperin, Percy, Winkler; for feminism, Friedan, Millett, Firestone, Dworkin (and Lorena Bobbit). Others will recognize biologists, sociobiologists, anthropologists, medical investigators, and, of course, Foucault. With so many varied ingredients, one wonders how this confection could have failed to rise. Throughout, there is a tendency to lead with the penis, as though much of social and medical history were driven by it alone. Thus, the early Western church's dicta against coitus interruptus, anal intercourse, and oral sex and its recognition of impotence as grounds for annulment of marriage are all attributed to penile obsession rather than the obvious concern for marriage and reproduction (43-45). Sweeping and often confused statements abound. Thus, "there is little doubt that the questions raised by da Vinci concerning man's relationship with his penis are the very questions that make that relationship the most enduring mystery in every man's life. This da Vinci realized four centuries before Sigmund Freud" (60). An interlude in the historical march through time reviews Western interest in the penis size of colonial natives from the sixteenth century onward. Says Friedman, contact with Africans "transformed the cultural role of the penis and significantly expanded its meaning as an idea," a "cultural shift" that was used to justify colonialism, castration, and slavery (105-6). The author claims that white fear of black sexual congress with white women developed only after emancipation! The perceived size difference, not race mixing per se, he maintains, motivated lynchings in the South and castrations of blacks, as "white men were sexually involved with black women" (128)! However, this digression contains a survey of later investigations and the latest data (on what whites? what blacks?), concluding with a rather insightful comment on Anita Hill versus Clarence Thomas as well as Robert Mapplethorpe. (His famous photograph, Man in a Polyester Suit, is included in the plates.) The chapter devoted to Freud provides a reasonable summary of the evolution of his views, addressing in passing Christian views of Jewish circumcision and concluding with President Clinton's sexual tangle. "[T]he life-and-death political struggle between Bill Clinton and his accusers was nothing less than a modern replay of the primal drama described in Totem and Taboo. . . . [C]ivilization requires sexual renunciation. Thus, for one man to act as though he has sexual...
Article
This study explored the experiences of men living with sexual dysfunction as a consequence of having been treated for prostate cancer. An ethnoculturally diverse sample of 18 men (14 heterosexual, and four homosexual) participated in a series of four to five in-depth interviews. These one-on-one interviews were designed to elicit information pertaining to their beliefs, values and performances regarding masculinity vis-a-vis prostate cancer and its treatment. Interview transcripts were analyzed using the grounded theory method. The core category of 'Preserving Manhood' incorporated five major themes: enhancing the odds; disrupting a core performance; baring an invisible stigma; effortful-mechanical sex; and working around the loss. We conclude that men's performances of sexuality and masculinity were highly interwoven; that loss of sexual functioning constituted a focal disruption for participants; and in some instances, posed a significant threat to their masculine identities.
Article
The objectives of this survey were to describe the prevalence of using a treatment for erectile dysfunction (ED) among men after therapy for localized prostate carcinoma and to construct models explaining the variance in trying a treatment, treatment success, and adherence to treatment. A postal survey was sent to 2636 men in The Cleveland Clinic Foundation's Prostate Cancer Registry who were treated initially with either definitive radiotherapy or prostatectomy for localized prostate carcinoma. The survey asked about demographic items, past and current sexual functioning, and the partner's sexual function. Men were asked about their current and intended use of medical treatments for ED. Standardized questionnaires included the Sexual Self-Schema Scale-Male Version, the International Index of Erectile Function, urinary and bowel symptom scales from the Los Angeles Prostate Cancer Index), and the Short-Form Health Survey. The return rate was 49%. Differences between men who returned the questionnaire and men who did not respond suggest that the sample was weighted toward men who were more interested in staying active sexually. ED was a problem for 85% of men, and 59% of this group used at least 1 treatment for ED. Only 38% of men found that a medical treatment was at least somewhat helpful in improving their sex lives, however, and 30% of respondents still were using at least 1 treatment at the time of the survey. Factors that were associated with the efficacy of treatments for ED and with their continued use included having a sexual partner, younger age, choosing a treatment for prostate carcinoma that was more likely to spare some sexual function, and not having had neoadjuvant or current antiandrogen therapy. Men who tried a greater number of treatments for ED were more likely to find one that worked. Men were more likely to continue using treatments for ED that produced greater improvements in sexual function. The success of medical treatments for men with ED among long-term survivors of prostate carcinoma is limited. Men prefer noninvasive treatments, although invasive treatments are more effective. Sexual counseling for men and their partners is recommended, because it may increase the use of medical therapies for ED. Creating more realistic expectations in both partners also may enhance treatment adherence.
Article
Prostate cancer is the most common malignancy in men and one of the leading causes of cancer death in men internationally. Treatment for prostate cancer frequently includes androgen deprivation therapy (ADT). Reports of depressive symptoms arising during ADT are emerging. This study examines the prevalence rates and risk factors associated with major depression in this population. 45 men with prostate cancer receiving ADT at the MGH Cancer Center were surveyed for depression with the SCID for Axis I disorders for DSM-IV and the Beck Depression Inventory. Major depressive disorder was prevalent in 12.8% of the men with prostate cancer receiving ADT, eight times the national rate of depression in men, 32 times the rate in men over 65 years old. Major depression was not associated with worsening disease, medical response to ADT, receiving chemotherapy, or the type of ADT. Past history of depression was associated with current depression in this population (p<0.000). No first onset cases of depression occurred on ADT in this sample. This data suggests a significant rate of major depression in men with prostate cancer receiving ADT and that men with past histories of depression may be at particular risk for recurrence of their depression while undergoing this treatment.
Article
To characterize the association between potency and comprehensive sexual function. The accurate assessment of sexual function is critical for the evaluation of outcomes after treatment of prostate cancer. The assessments of potency typically used in this context, however, may be oversimplified. CaPSURE is a large, observational database of men with prostate cancer. Participants complete health-related quality-of-life questionnaires, including the University of California, Los Angeles Prostate Cancer Index, every 6 months after treatment. A total of 5135 men completed at least one questionnaire and did not use medications for erectile function. The men were categorized as potent or impotent based on their ability to have erections and/or intercourse in the prior 4 weeks. Using the remaining questions on the Prostate Cancer Index, sexual function and bother scores were calculated for each group. Of the 5135 men, 27.4% were potent. The mean sexual function scores were 56 and 13 for potent and impotent men, respectively (P <0.0001). The corresponding mean bother scores were 62 and 36 (P <0.0001). The function scores ranged from 0 to 100 and 0 to 92 among potent and impotent men, respectively, and bother scores from 0 to 100 in both groups. Function was inversely associated with age in both groups, but bother did not change among potent men and ameliorated among impotent men. Individual Prostate Cancer Index questions correlated with potency to a variable extent. Although potent and impotent men have divergent sexual function and bother scores after treatment, the wide range of these scores in both groups denotes a complex picture of sexual function. The simple documentation of potency after treatment provides an insufficient measure of sexual health-related quality of life and should be supplemented with more comprehensive measures.